Skip to content

Lead Pharma Holding B.V.

Ongoing bankruptcy
4 financial reports
KvK
74987283
Establishment
Oss, Noord-Brabant
Sector
Not known
Bankruptcy number
F.01/25/320
Insolvency practitioner
mr. D.P. Schalken, BG.Legal

Summary

Lead Pharma Holding B.V. was declared bankrupt by the Rechtbank Oost-Brabant on November 25, 2025 (insolvency number F.01/25/320). The company is a BV established in Oss (Noord-Brabant). It is registered in the Dutch Commercial Register under KvK number 74987283. The company was founded on June 3, 2019. The insolvency practitioner is mr. D.P. Schalken of BG.Legal. The supervisory judge is mr. S.C.E.F. Moulen Janssen. There are 4 public reports; the latest is report 4 of October 6, 2026. In addition, there are 4 financial reports; the latest is financial report 4 of October 6, 2026. Based on the earlier reports, on average every 91 days, the next report is expected around January 5, 2027. Estate assets according to financial report 4: €55,640.80. Key figures according to report 4: unsecured claims €30,410.44, creditors 5 en preferential claims €171,586.56. Causes of the bankruptcy according to report 4: completed.

In the past twelve months, 473 bankruptcies were declared in Noord-Brabant. Of these, 17 came from the municipality of Oss.

Unsecured claims according to report 4 of October 6, 2026: €30,410.44 (in report 3 of July 6, 2026: €17,914.29).

Hours spent according to report 4 of October 6, 2026: 68 h 24 min (in report 3 of July 6, 2026: 62 h 24 min).

In report 4, the reported position changed as follows: restart (going-concern sale) from completed to mentioned, filing of annual accounts from under investigation to not applicable, and lawfulness investigation from under investigation to mentioned.

Employees according to report 4 of October 6, 2026: 2.

Submit a claim

Creditors submit their claim in writing to the insolvency practitioner, stating insolvency number F.01/25/320 and enclosing the supporting documents.

Deadline for submission
Not published

New since report 4

10 changes

Public report 4 of October 6, 2026, compared with report 3 of July 6, 2026

Compare report 3 and report 4

New

  • Estate debts

    €67,272.49

  • Preferential claims

    €171,586.56

  • Creditors

    5

Changed

No longer mentioned

  • Claims of secured creditors

    Claims of secured creditors is no longer mentioned.

  • Estate account balance

    Estate account balance is no longer mentioned.

Estate assets Fin. report 4
€55,640.80, history of Estate assets

unchanged

Unsecured claims Report 4
€30,410.44, history of Unsecured claims

+€12,496.15 since report 3

Preferential Report 4
€171,586.56, history of Preferential

unchanged

Creditors Report 4
5, history of Creditors

+2 since report 2

Employees Report 4
2, history of Employees

unchanged

Further case information

Status

Rent and lease
Mentioned Rent and lease
Causes of the bankruptcy
Completed Causes of the bankruptcy
Het rechtmatigheidsonderzoek heeft de lezing van het bestuur bevestigd en geeft geen aanleiding om hier nog nadere actie op te ondernemen. Dit is 4 afgerond. Echter, de levering van IE-rechten kan nog niet volledig afgerond w orden, zodat dit nog niet het eindverslag is. De curator is in afw achting van groen licht om de resterende IE-rechten te leveren aan de beoogd nieuw e houder ervan.
Staff
Mentioned Staff
Sale of assets
Mentioned Sale of assets
Collection of receivables
Mentioned Collection of receivables
Security rights
Mentioned Security rights
Restart (going-concern sale)
Mentioned Restart (going-concern sale)
Bookkeeping obligation
Mentioned Bookkeeping obligation
Filing of annual accounts
Not applicable Filing of annual accounts
Director liability
Mentioned Director liability
Actio pauliana
Mentioned Actio pauliana
Legal proceedings
Mentioned Legal proceedings
Lawfulness investigation
Mentioned Lawfulness investigation

Recent timeline

  1. Public report of October 6, 2026 published

  2. Public financial report of October 6, 2026 published

Key documents

  • Verslag: 06-10-2026

    10-06-2026 13 p. Rechtspraak

    View
  • Financieel verslag 06-10-2026

    10-06-2026 10 p. Rechtspraak

    View
  • Verslag: 06-07-2026

    07-06-2026 13 p. Rechtspraak

    View
  • Financieel verslag 06-07-2026

    07-06-2026 10 p. Rechtspraak

    View

Questions and answers about Lead Pharma Holding B.V.

Which bankruptcy trustee is handling the case of Lead Pharma Holding B.V.?

mr. D.P. Schalken of BG.Legal has been appointed bankruptcy trustee by the Rechtbank Oost-Brabant. For questions about the bankruptcy, contact the bankruptcy trustee.

Since when has Lead Pharma Holding B.V. been bankrupt?

The Rechtbank Oost-Brabant declared bankrupt Lead Pharma Holding B.V. on November 25, 2025. The insolvency number is F.01/25/320.

How do I submit a claim in the bankruptcy of Lead Pharma Holding B.V.?

You submit a claim in writing to the insolvency practitioner, mr. D.P. Schalken of BG.Legal. Enclose the documents that support it, such as invoices and contracts, and state insolvency number F.01/25/320.

What does the bankruptcy of Lead Pharma Holding B.V. involve for creditors?

After the declaration of bankruptcy, the insolvency practitioner decides on the company's assets, not the company itself. The insolvency practitioner sells what there is and distributes the proceeds according to the statutory ranking. Whether ordinary creditors receive anything usually only becomes clear at the end.

Where can I find the reports on the bankruptcy?

4 public reports have been published; the latest appeared on October 6, 2026. You can read them under Reports in this case.

Company details

Legal form
BV
Founded
June 3, 2019
KvK registration
Active
Special legal status
Bankruptcy

Sources

Not known: sbi code, trade names

Addresses

  • Business address Correspondence address Trading address
    Kloosterstraat 9 5349 AB Oss
    • Built in 2004
    • industriefunctie
    • 87 m²

Affiliated companies